{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:30:43Z","timestamp":1781195443953,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.neulet.2016.02.042","type":"journal-article","created":{"date-parts":[[2016,2,25]],"date-time":"2016-02-25T10:11:39Z","timestamp":1456395099000},"page":"146-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Effects of different isoforms of apoE on aggregation of the \u03b1\u2010synuclein protein implicated in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"618","author":[{"given":"Fatemeh Nouri","family":"Emamzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmesh","family":"Aojula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C.","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Allsop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2016.02.042_bib0005","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2016.02.042_bib0010","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of \u03b1-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2016.02.042_bib0015","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"\u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2016.02.042_bib0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00401-012-1013-5","article-title":"The genetics and neuropathology of Parkinson\u2019s disease","volume":"124","author":"Houlden","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neulet.2016.02.042_bib0025","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in \u03b1-synuclein mice: implications for neurodegenerative disorders","volume":"287","author":"Masliah","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neulet.2016.02.042_bib0030","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","article-title":"Neuronal \u03b1-synucleinopathy with severe movement disorder in mice expressing A53T human \u03b1-synuclein","volume":"34","author":"Giasson","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2016.02.042_bib0035","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20130092","article-title":"The interplay between lipids and dopamine on \u03b1-synuclein oligomerization and membrane binding","volume":"33","author":"Pham","year":"2013","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.neulet.2016.02.042_bib0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1750-1326-4-9","article-title":"\u03b1-Synuclein and neuronal cell death","volume":"4","author":"Cookson","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neulet.2016.02.042_bib0045","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neulet.2016.02.042_bib0050","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ajpa.21298","article-title":"Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations, and evolutionary history","volume":"143","author":"Eisenberg","year":"2010","journal-title":"Am. J. Phys. Anthropol"},{"key":"10.1016\/j.neulet.2016.02.042_bib0055","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJMoa0809437","article-title":"Longitudinal modelling of age-related memory decline and the APOE epsilon4 effect","volume":"361","author":"Caselli","year":"2009","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.neulet.2016.02.042_bib0060","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/372092a0","article-title":"Amyloid-associated proteins 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer \u03b2-protein into filaments","volume":"372","author":"Ma","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2016.02.042_bib0065","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1073\/pnas.91.23.11183","article-title":"Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease","volume":"91","author":"Strittmatter","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2016.02.042_bib0070","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","article-title":"Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice","volume":"24","author":"Brecht","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2016.02.042_bib0075","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/nature04001","article-title":"Apolipoprotein-mediated pathways of lipid antigen presentation","volume":"437","author":"van den Elzen","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2016.02.042_bib0080","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1212\/01.wnl.0000254468.51973.44","article-title":"APOE \u03b54 is associated with impaired verbal learning in patients with MS","volume":"68","author":"Koutsis","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2016.02.042_bib0085","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1212\/WNL.0b013e3181e074a7","article-title":"APOE \u03b54 and the cognitive genetics of multiple sclerosis","volume":"74","author":"Ghaffar","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2016.02.042_bib0090","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.ajpath.2011.07.021","article-title":"Apolipoprotein E and LRP1 increase early in Parkinson\u2019s disease pathogenesis","volume":"179","author":"Wilhelmus","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neulet.2016.02.042_bib0095","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1523\/JNEUROSCI.5471-06.2007","article-title":"Apolipoprotein E-containing lipoproteins protect neurons from apoptosis via a signaling pathway involving low-density lipoprotein receptor-related protein","volume":"27","author":"Hayashi","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2016.02.042_bib0100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nn2058","article-title":"A molecular pathway of neurodegeneration linking \u03b1-synuclein to ApoE and A\u03b2 peptides","volume":"11","author":"Gallardo","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neulet.2016.02.042_bib0105","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00415-009-0119-8","article-title":"Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson\u2019s disease","volume":"256","author":"Williams-Gray","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.neulet.2016.02.042_bib0110","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.neurobiolaging.2011.05.016","article-title":"Apolipoprotein E genotypes and the risk of Parkinson disease","volume":"32","author":"Gao","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2016.02.042_bib0115","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1212\/WNL.56.2.194","article-title":"APOE genotype predicts AD and other dementia but not ischemic cerebrovascular disease","volume":"56","author":"Frikke-Schmidt","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2016.02.042_bib0120","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ajmg.10111","article-title":"Age at onset of Parkinson disease and apolipoprotein E genotypes","volume":"107","author":"Zareparsi","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neulet.2016.02.042_bib0125","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1096\/fj.03-1449com","article-title":"Detection of oligomeric forms of \u03b1-synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease","volume":"20","author":"El-Agnaf","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.neulet.2016.02.042_bib0130","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jmb.2006.06.080","article-title":"Amino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils","volume":"361","author":"Hatters","year":"2006","journal-title":"J. Mol. Biol"},{"key":"10.1016\/j.neulet.2016.02.042_bib0135","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/0-387-23226-5_13","article-title":"The interaction of amyloid-\u03b2 with ApoE","volume":"38","author":"Carter","year":"2005","journal-title":"Subcell. Biochem"},{"key":"10.1016\/j.neulet.2016.02.042_bib0140","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1073\/pnas.1218424110","article-title":"Large \u03b1-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking","volume":"110","author":"Choi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2016.02.042_bib0145","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1096\/fj.03-0098fje","article-title":"\u03b1-Synuclein implicated in Parkinson\u2019s disease is present in extracellular biological fluids, including human plasma","volume":"17","author":"El-Agnaf","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.neulet.2016.02.042_bib0150","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awt037","article-title":"Prion-like spreading of pathological \u03b1-synuclein in brain","volume":"136","author":"Masuda-Suzukake","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2016.02.042_bib0155","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/biom5020282","article-title":"Seeking a mechanism for the toxicity of oligomeric \u03b1-synuclein","volume":"5","author":"Roberts","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.neulet.2016.02.042_bib0160","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4137\/BMI.S11422","article-title":"Quantitative appraisal of ventricular cerebrospinal fluid biomarkers in neuropathologically diagnosed Parkinson\u2019s disease cases lacking Alzheimer\u2019s disease pathology","volume":"8","author":"Maarouf","year":"2013","journal-title":"Biomark Insights"},{"key":"10.1016\/j.neulet.2016.02.042_bib0165","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1002\/jnr.21452","article-title":"Proteomic identification of biomarkers in the cerebrospinal fluid in a rat model of nigrostriatal dopaminergic degeneration","volume":"85","author":"Rite","year":"2007","journal-title":"J. Neurosci. Res."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394016301082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394016301082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T11:30:36Z","timestamp":1616239836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394016301082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":33,"alternative-id":["S0304394016301082"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2016.02.042","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of different isoforms of apoE on aggregation of the \u03b1\u2010synuclein protein implicated in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2016.02.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}